08 April 2020

We aim to provide members with both general and haematology specific up-to-date COVID-19 information.  This page will be reviewed every day and updated as necessary. If you would like to add any resources please contact: Saskia@b-s-h.org.uk

General Haematology
Aplastic Anaemia Guidance (Last Updated 03/04/2020)

King’s College Hospital has released guidance for treating adult aplastic anaemia/bone marrow failure patients during the COVID-19 outbreak.

Click here to read the guidance.

BJHaem Articles (Last Updated 17/03/2020)

The BJHaem have published open-access articles about COVID-19.

Click the links below to read these articles

Care of haematology patients in a COVID‐19 epidemic

How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID‐19 threat?

BSH Advice on B12 Supplements

This is the BSH guidance on B12 supplements during COVID pandemic.

Read the guidance here 

Diamond Blackfan Anaemia Advice (Last Updated: 25/03/2020)

These documents were made in a collaboration between the Haemoglobinopathy Co-ordinating Centres in England, offering guidance to health professionals working with patients with Diamond Blackfan anaemia (DBA). It has been reviewed and agreed by representatives of the Haemoglobinopathy Co-ordinating Centres in England and the Clinical Reference Group for Haemoglobin disorders and DBA(UK). 

Click the links below to download advice:

NHP COVID-19 Guidance (PDF version)

NHP COVID-19 Guidance: Patients Version (PDF version)

 

Immune Thrombocytopenia (ITP) Information (Last Updated 19/03/2020)

The UK ITP Forum, has provided information for adult patients with immune thrombocytopenia in the setting of the COVID-19 .

Click here to read the document

NICE COVID-19 guidelines (Last Updated 23/03/2020)

NICE new guidelines cover the management of patients in critical care, the management of patients who are having kidney dialysis and the management of patients who are receiving systemic anticancer treatments.

It should be noted that due to the need to publish these very rapidly they have not gone through the usual NICE guidance development process.

Sickle cell and Thalassaemia
Sickle Cell Disease & Thalassaemia Advice (Last Updated: 21/03/2020)

The haemoglobinopathy co-ordinating centres have developed advice for the management of COVID-19 in patients with Sickle Cell Disease and Thalassaemia. 

Please click here to read advice

Haemoglobinopathy Co-ordinating Centres (Last Updated 06/04/2020)

A statement has been released from the Haemoglobinopathy Co-ordinating Centres.

Please read the statement here

Haemato-Oncology
Blood Cancer UK guidance (Last Updated: 18/03/2020)

The charity Blood Cancer UK has issued guidance about the coronavirus COVID-19 aimed at blood cancer patients, setting out those at greatest risk and what measures should be taken.

Many haematology patients who have blood cancers suffer from suppressed immune systems. The World Health Organisation recently declared the COVID-19 outbreak a pandemic, urging countries to take all possible steps to limit the spread of the virus.

Blood Cancer UK advises that healthcare professionals can help reduce the risk to blood cancer patients may be able to conduct appointments remotely if possible, such as over the telephone or a video call. This will help avoid bringing patients to crowded clinics during the outbreak.This advice includes that at-risk patients and their carers should avoid crowded places. They should distance themselves from places where there might be other people with the virus, the charity says.

Patients do not need to isolate themselves at home – as activities such as walking in a park should not pose a risk, according to chief executive Gemma Peters.

She warns that hospitals are places where patients are at greatest risk. Phone and video appointments should be used where possible – and blood tests can be scheduled away from hospital sites.

Gemma Peters says that patients who need to go to hospital for treatment should attend – and the teams caring for them will take every possible precaution.

She said: “Things with blood cancer are a little bit different as more people are more likely to be immunosuppressed than in other kinds of cancer.”

People with weakened immune systems who are at increased risk of complications from coronavirus include:

  • People having chemotherapy, or who’ve had chemotherapy in the last 3 months;
  • People having immunotherapy or other antibody treatments for cancer;
  • People having targeted cancer treatments that can affect the immune system, such as protein kinase inhibitors;
  • People who’ve had a bone marrow or stem cell transplant in the last 6 months, or who are still taking immunosuppression drugs; and
  • People with some types of blood cancer which affect the immune system, such as chronic leukaemia, lymphoma or myeloma, even if no treatment is being given.

https://bloodwise.org.uk/blog/coronavirus-and-blood-cancer

BSBMTCT Recommendations (Last Updated: 18/03/2020)

The British Society of Blood and Marrow Transplantation and Cellular Therapy(BSBMTCT) have created recommendations for adult patients with COVID-19.

Click here to read the recommendations

Chronic Myeloid Leukaemia (Last Updated 23/03/2020)

The National Cancer Research Institute (NCRI) has created COVID-19 (coronavirus) advice for patients with Chronic Myeloid Leukaemia receiving TKI therapy.

Please click here to read this advice

EBMT Recommendations (Last Updated: 18/03/2020)

The European Society for Blood and Marrow Transplantation (EBMT) have issued recommendations for recipients and donors of hematopoietic cells before the beginning of any of the transplant procedures (mobilization, apheresis, marrow harvest, conditioning). These guidelines will be updated when new information is obtained about COVID-19 epidemiology and clinical outcome.

Click here to read current guidelines

To read more from the EBMT, please click link below: 

https://www.ebmt.org/ebmt/news/coronavirus-disease-covid-19-ebmt-recommendations-update-march-16-2020

Myeloproliferative Neoplasms Advice (Last updated 30th March 2020)

MPN Voice provides information and emotional support to everyone who has been diagnosed with a myeloproliferative neoplasm (MPN) and their families.  Therefore, like many other organizations during the COVID-19 outbreak, MPN Voice are providing people with information issued by the NHS and the Government. 

Click here to read this advice

UK/Ireland Paed BMT group guidelines (Last updated 23/03/2020)

The UK/Ireland Paediatric BMT group has created practical guidelines for the prevention and management of COVID-19 in paediatric HSCT patients. 

Please note: These guidelines are purely advisory and should be implemented in the context of advice from Dept of Health, your Trust management and Infection Control teams and will evolve as the situation changes.

Click here to read the guidelines. 

UK Myeloma Forum (Last Updated 27/03/2020)

The UK Myeloma Forum has released guidance on treating patients in the current COVID-19 pandemic.

Click here to read this guidance.

Transfusion
BSBMTCT Recommendations (Last Updated: 18/03/2020)

The British Society of Blood and Marrow Transplantation and Cellular Therapy(BSBMTCT) have created recommendations for adult patients with COVID-19.

Click here to read the recommendations

EBMT Recommendations (Last Updated: 18/03/2020)

The European Society for Blood and Marrow Transplantation (EBMT) have issued recommendations for recipients and donors of hematopoietic cells before the beginning of any of the transplant procedures (mobilization, apheresis, marrow harvest, conditioning). These guidelines will be updated when new information is obtained about COVID-19 epidemiology and clinical outcome.

Click here to read current guidelines

To read more from the EBMT, please click link below: 

https://www.ebmt.org/ebmt/news/coronavirus-disease-covid-19-ebmt-recommendations-update-march-16-2020

General Transfusion advice (Last updated 25/03/2020)

During the COVID-19 pandemic, it is important, that patients are able to still receive blood transfusions if and when needs be. This link contains information on current blood and platelets stocks and also other key resources from NHS Blood and Transplant and the National Blood Transfusion Committee included Emergency Blood shortage plans for hospitals.

Please click the link below to access the information:

https://hospital.blood.co.uk/business-continuity/coronavirus-covid-19/

 

Other Transfusion Resources:

https://www.transfusionguidelines.org/

https://hospital.blood.co.uk/business-continuity/coronavirus-covid-19/

Haemostasis and Thrombosis
Disseminated Intravascular Coagulation (Last Updated 01/04/2020)

The BSH Guidelines committee has produced specific information for haematologists that should be used as an adjunct to the overarching advice from Public Health England.

Please click the links below to read:

DIC Score in COVID-19 Pneumonia 

INR testing for out-patients on warfarin (Last updated 24/03/2020)

The BSH Haemostasis and Thrombosis Task Force has created guidance on INR testing for out-patients on warfarin during COVID-19 restrictions.

Click here to read this guidance

PCR Positivity for COVID-19 (Last Updated 19/03/2020)

The BSH Guidelines committee has produced specific information for haematologists that should be used as an adjunct to the overarching advice from Public Health England.

Please click the link below to read:

PCR Positivity for COVID-19 in blood samples